| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |